Mankind Pharma Limited — Important, 23-10-2024: General Updates

Mankind Pharma has successfully completed the acquisition of a 100% stake in Bharat Serums and Vaccines Limited (BSV) for INR 13,768 crores. This strategic move enhances Mankind's leadership in the women's health and fertility market and strengthens its portfolio in critical care. The acquisition leverages BSV's R&D capabilities and aims for increased revenue and EBITDA margins. Mankind plans to optimize operations and expand its market reach, welcoming BSV's team into its family.